Alkeon Capital Management Portfolio holdings
AUM
$20.6B
This Quarter Return
+3.59%
1 Year Return
+8.97%
3 Year Return
+43.14%
5 Year Return
+49.88%
10 Year Return
+256.15%
AUM
$16.7B
AUM Growth
+$16.7B
(+7%)
Cap. Flow
-$340M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
43.87%
Holding
119
New
3
Increased
29
Reduced
49
Closed
9
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$444M |
| 2 |
Microsoft
MSFT
|
$209M |
| 3 |
Invesco QQQ Trust
QQQ
|
$157M |
| 4 |
New Oriental
EDU
|
$120M |
| 5 |
Amazon
AMZN
|
$113M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$220M |
| 2 |
Pinduoduo
PDD
|
$113M |
| 3 |
TSMC
TSM
|
$83.5M |
| 4 |
Lam Research
LRCX
|
$79.8M |
| 5 |
Synopsys
SNPS
|
$75.8M |
Sector Composition
| 1 | Technology | 37.85% |
| 2 | Communication Services | 20.81% |
| 3 | Consumer Discretionary | 18.59% |
| 4 | Financials | 8.71% |
| 5 | Healthcare | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Elastic
ESTC
$9.17B
| $70.3M | 0.12% |
1,095,985
+125,716
| +13% | +$8.06M |
|
52
S&P Global
SPGI
$165B
| $68.1M | 0.12% |
169,892
-108,457
| -39% | -$43.5M |
|
53
Dell
DELL
$83.9B
| $67.6M | 0.12% |
+1,250,000
| New | +$67.6M |
|
54
Keros Therapeutics
KROS
$638M
| $67.4M | 0.12% |
1,676,522
-1,496
| -0.1% | -$60.1K |
|
55
Dynatrace
DT
$15.1B
| $66.4M | 0.12% |
1,290,626
-74,961
| -5% | -$3.86M |
|
56
XP
XP
$9.38B
| $61.4M | 0.11% |
2,617,617
-373,922
| -12% | -$8.77M |
|
|
BPMC
57
DELISTED
Blueprint Medicines
BPMC
| $59.7M | 0.1% |
943,928
+591,745
| +168% | +$37.4M |
|
58
Paylocity
PCTY
$9.6B
| $58.9M | 0.1% |
319,024
-40,438
| -11% | -$7.46M |
|
59
Sarepta Therapeutics
SRPT
$1.98B
| $58.3M | 0.1% |
508,845
-203,989
| -29% | -$23.4M |
|
60
Global Payments
GPN
$21B
| $48.8M | 0.09% |
495,772
-176,066
| -26% | -$17.3M |
|
61
KKR & Co
KKR
$120B
| $45.8M | 0.08% |
818,076
-116,873
| -13% | -$6.54M |
|
62
TG Therapeutics
TGTX
$5.03B
| $38.4M | 0.07% |
1,547,875
-1,142,048
| -42% | -$28.4M |
|
63
dLocal
DLO
$4.09B
| $36.9M | 0.06% |
3,020,287
+1,138,699
| +61% | +$13.9M |
|
|
GTM
64
ZoomInfo Technologies
GTM
$3.31B
| $36.8M | 0.06% |
1,450,662
+150,266
| +12% | +$3.82M |
|
65
Sea Limited
SE
$107B
| $32.7M | 0.06% |
563,168
-603,743
| -52% | -$35M |
|
66
Cintas
CTAS
$82.9B
| $29.5M | 0.05% |
237,196
-33,884
| -12% | -$4.21M |
|
67
Rhythm Pharmaceuticals
RYTM
$6.75B
| $28.4M | 0.05% |
1,725,167
-290,799
| -14% | -$4.8M |
|
|
XYZ
68
Block, Inc.
XYZ
$46.2B
| $26.6M | 0.05% |
+400,000
| New | +$26.6M |
|
69
Xometry
XMTR
$2.37B
| $23.3M | 0.04% |
1,101,989
+90,701
| +9% | +$1.92M |
|
70
Oric Pharmaceuticals
ORIC
$1.03B
| $23.1M | 0.04% |
2,979,289
+580,037
| +24% | +$4.5M |
|
|
CERE
71
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $22.2M | 0.04% |
699,695
-36,826
| -5% | -$1.17M |
|
72
TransUnion
TRU
$16.8B
| $21.1M | 0.04% |
269,915
-101,702
| -27% | -$7.97M |
|
73
JFrog
FROG
$5.58B
| $16.9M | 0.03% |
608,885
-90,581
| -13% | -$2.51M |
|
74
Stem
STEM
$122M
| $16.5M | 0.03% |
144,431
+45,237
| +46% | +$5.18M |
|
|
KLRS
75
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $15.7M | 0.03% |
200,222
| – | – |
|